Get started
AKER BIOMARINE ASAAA

AKER BIOMARINE ASA

64.4NOKD
−0.7−1.08%
At close at Mar 7, 15:26 GMT
NOK
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals Bonds

AKBM fundamentals

Key facts

Market capitalization‪5.65 B‬NOK
Dividend yield (indicated)0.00%
Price to earnings Ratio (TTM)2.88
Basic EPS (TTM)22.60NOK
Founded2013
Employees (FY)—
CEOMatts Eirik Johansen
Websiteakerbiomarine.com
About

Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. It operates through the Ingredients and Brands segments. The Ingredients segment includes offshore harvesting and production activities, logistical operations, and the onshore manufacturing and sale of krill oil products globally to distributors and feed producers. The Brands segment relates to the group legal entities Lang Pharma Nutrition LLC, Epion Brands LLC , and the holding company New Ride LLC. The company was founded in 2006 and is headquartered in Lysaker, Norway.

Ownership
‪‪87.70 M‬‬
Closely held shares
‪‪83.46 M‬‬ (95.16%)
Free Float shares
‪‪4.24 M‬‬ (4.84%)
Closely held shares
‪‪83.46 M‬‬ (95.16%)
Free Float shares
‪‪4.24 M‬‬ (4.84%)
Capital structure
Market cap
‪‪5.65 B‬‬
Debt
‪‪1.68 B‬‬
Cash & equivalents
‪‪170.36 M‬‬
Enterprise value
‪‪7.15 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪5.65 B‬‬
Price to earning ratio (P/E)
2.88x
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
2.88x
Price to sales ratio (P/S)
—
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪1.70 K‬‬
‪‪3.40 K‬‬
‪‪5.10 K‬‬
‪‪6.80 K‬‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−22%‬
‪−11%‬
‪0%‬
‪11%‬
‪22%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−800.00 M‬‬
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−200.00 M‬‬
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−200.00 M‬‬
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Ingredients
Brands
By country
Period: 2024
Americas
Asia Pacific
EMEA
Norway

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
‪‪1.20 B‬‬
Actual
Estimate
Earnings
Next:Apr 30, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−2.40‬
‪−1.60‬
‪−0.80‬
‪0.00‬
‪0.80‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
0.00%
Last payment
45.00
Last ex-date
Sep 9, 2024
Dividend history
‪0%‬
2020
2021
2022
2023
2024
‪0.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−1.50 B‬‬
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪700.00 M‬‬
‪‪1.40 B‬‬
‪‪2.10 B‬‬
‪‪2.80 B‬‬
Assets
Liabilities